Terms: = Skin cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
63 results:
1. The Association of Melanoma-Associated Antigen-C Gene With Clinicopathological Characteristics and prognosis in Breast cancer: A Systematic Review and Meta-Analysis.
Lin X; Huo J; Su H; Xu Y; Zhang F
Clin Breast Cancer; 2024 Jan; 24(1):7-16. PubMed ID: 37872029
[TBL] [Abstract] [Full Text] [Related]
2. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
3. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract] [Full Text] [Related]
4. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.
Zhou D; Li M; Xu F; Zheng Q; Lu Q; Hong R; Wang S
Ann Med; 2023 Dec; 55(1):2232299. PubMed ID: 37431586
[TBL] [Abstract] [Full Text] [Related]
6. The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated her2-negative breast cancer with brain metastases.
Chen X; Bai X; Xie X; Huang J; Chen L; Song L; Lan X; Zhang Q; Guo J; Du C
Ann Med; 2023 Dec; 55(1):2218647. PubMed ID: 37260331
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of her-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
[No Abstract] [Full Text] [Related]
8. [Eight Cases of Breast cancer That Relapsed More Than Ten Years after Initial Treatment].
Yoshimura A; Ueda T; Tanaka T; Kirihataya Y; Soga M; Yokotani T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1935-1937. PubMed ID: 36733049
[TBL] [Abstract] [Full Text] [Related]
9. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract] [Full Text] [Related]
10. Immune checkpoint inhibitors combined with her-2 targeted therapy in her-2 positive gastroesophageal cancer.
Aisa A; Weng S; Li X; Zhang D; Yuan Y
Crit Rev Oncol Hematol; 2022 Dec; 180():103864. PubMed ID: 36332788
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of potent and selective her2 PROTAC degrader based Tucatinib with improved efficacy against her2 positive cancers.
Hu M; Li Y; Li J; Zhou H; Liu C; Liu Z; Gong Y; Ying B; Xie Y
Eur J Med Chem; 2022 Dec; 244():114775. PubMed ID: 36208507
[TBL] [Abstract] [Full Text] [Related]
12. Reduced Expression of KRT17 Predicts Poor prognosis in her2
Tang S; Liu W; Yong L; Liu D; Lin X; Huang Y; Wang H; Cai F
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139022
[TBL] [Abstract] [Full Text] [Related]
13. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
Shu W; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Zhu H; Zhu L; Murray M; Zhou F
Cell Oncol (Dordr); 2022 Aug; 45(4):601-619. PubMed ID: 35781872
[TBL] [Abstract] [Full Text] [Related]
14. Ado-trastuzumab emtansine associated spider telangiectasia.
Gursoy P; Acar A; Acikalin T
J Oncol Pharm Pract; 2022 Jun; 28(4):986-988. PubMed ID: 35040682
[TBL] [Abstract] [Full Text] [Related]
15. The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease.
Evans A; Sim YT; Lawson B; Macaskill J; Jordan L; Thompson A
Breast Cancer; 2022 Mar; 29(2):296-301. PubMed ID: 34780035
[TBL] [Abstract] [Full Text] [Related]
16. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-erbb2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract] [Full Text] [Related]
17. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract] [Full Text] [Related]
18. Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
Yamashita Y; Tsunoda H; Nagura N; Kajiura Y; Yoshida A; Takei J; Suzuki K; Watanabe T; Iwahira Y; Yamauchi H; Hayashi N
Clin Breast Cancer; 2021 Aug; 21(4):352-359. PubMed ID: 33526379
[TBL] [Abstract] [Full Text] [Related]
19. [Two Cases of Breast cancer with Extensive Invasion to skin].
Maruo K; Nishimori T; Takemura S; Sakurai Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2275-2277. PubMed ID: 33468932
[TBL] [Abstract] [Full Text] [Related]
20. Inflammatory Breast cancer in Pregnancy and Lactation.
Linhares S; Alrammah T; Alghamdi HA; Möller MG
Adv Exp Med Biol; 2020; 1252():143-151. PubMed ID: 32816275
[TBL] [Abstract] [Full Text] [Related]
[Next]
